Up for 8 straight weeks, is Altimmune (ALT) stock a good buy?

The Altimmune (NASDAQ: ALT) stock price has been in a strong uptrend in the past few months. It bottomed at $2.07 in October, and the shares have surged by over 475% to its highest level since February. This rally has brought its total market cap to more than $629 million.Why is ALT shares soaring?Copy link to sectionAltimmune share price has been in a strong uptrend in the past few months as demand for weight loss drugs continued rising. Its drug, known as Pemvidutide, which it acquired in 2019, has shown ...